文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > Thrombectomy for Acute Ischemic Stroke Treatment
侵权投诉

Thrombectomy for Acute Ischemic Stroke Treatment

Thrombectomy for Acute Ischemic Stroke Treatment

The eJournal of the European Society of Minimally Invasive Neurological Therapy

Thrombectomy for Acute Ischemic Stroke Treatment: A Review

EJMINT Invited Review, 2012: 1238000077 (21st September 2012)

Pasquale Mordasini, Christoph Zubler, Gerhard Schroth, Jan Gralla

Abstract

Mechanical treatment approaches for acute ischemic stroke treatment aim for fast and efficient reperfusion with short procedure times and high recanalisation rates, thus extending the treatment window. We review the current literature on mechanical thrombectomy for the treatment of acute ischemic stroke.

Keywords: endovascular, stroke treatment, mechanical thrombectomy, stent retriever

Abbreviations IAT

IV rtPA

IMS III

MERCI Trial

TREVO 2 study

STAR Trial

SWIFT study

sICH intra-arterial thrombolysis intra-venous administration of tissue plasminogen activator Interventional Management of Stroke III Trial Mechanical Embolus Removal in Cerebral Ischemia Thrombectomy REvascularisation of Large Vessel Occlusions in acute ischemic stroke Solitaire FR Thrombectomy for Acute Revascularisation Solitaire FR with the Intention for Thrombectomy symptomatic intracranial haemorrhage

Introduction

Acute ischemic stroke is a major cause of death or disability in industrialised countries. Significant modifiable factors influencing the clinical outcome are the time span between symptom onset and

revascularisation, recanalisation rate and the occurrence of symptomatic intracranial haemorrhage (sICH)

[1]. Recanalisation has been shown to be the most important modifiable prognostic factor for favorable outcome in ischemic stroke treatment. Successful recanalisation overall increases the chance of

favourable outcome 4-fold compared to patients without recanalisation, and decreases the mortality rate 4-fold [1]. The importance of recanalisation is even more pronounced in basilar artery occlusion, where the chance of an independent life is only 2 % in patients without recanalisation [2].

Systemic thrombolysis with intra-venous administration of tissue plasminogen activator (IV rtPA) and local intra-arterial thrombolysis (IAT) have been shown to be effective and to improve patients’ outcome

compared to placebo [3-5]. However, pharmacological thrombolysis with both methods has limitations and disadvantages. First, the time window for treatment and therefore recanalisation is limited [5-7]. Second, the administration of thrombolytic drugs might increase the risk of sICH [8]. Third, recanalisation success depends on the site of vessel occlusion: proximal large vessel occlusion such as the ICA or M1 segment have a limited recanalisation rate after IAT and especially after IV rtPA [7-8].

Thrombectomy for Acute Ischemic Stroke Treatment: A Review

Pasquale Mordasini MD MSc, Christoph Zubler MD, Gerhard Schroth MD, Institute of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Switzerland

Jan Gralla MD MSc (Corresponding Author) Department of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Freiburgstrasse 4, CH-3010 Bern, Switzerland

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email